AKR1C3 and chronic myelogenous leukemia, BCR-ABL1 positive: Considering this phenomenon and the results obtained with DDX knockout and treatment with FL118, we proposed a molecular mechanism by which enhanced expression of DDX5 positively regulates proliferation and survival of BCR-ABL-positive CML cells (Figure 10).